The stabilization of IκBα by proteasome inhibition is often referred to as a mechanism by which pro-survival NFκB signaling branches that can be triggered by death receptor activation are blocked, yet NFκB signaling surprisingly might have a pro-death function specifically in the glioma setting [44]. Here, NFKB1 is linked to central nervous system cancer.